🇺🇸 FDA
Patent

US 9128093

Selective cytopheresis devices and related methods thereof

granted A61KA61K31/34A61P

Quick answer

US patent 9128093 (Selective cytopheresis devices and related methods thereof) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Sep 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
38
CPC classes
A61K, A61K31/34, A61P, A61P1/00, A61P1/04